Pharmaceutical companies are struggling with what it means to be digitally transformed and how to reach Industry 4.0. Where to start? Company culture.

How do we meet the expectations of a growing population, but also address sustainability? This short video featuring Antonio Pietri, CEO Aspen Technology, discusses this dual challenge and the new levels of operational excellence in the capital intensive industries.

A medida que las empresas de energía, química y EPC continúan ajustándose a una nueva normalidad, el enfoque en cumplir los objetivos de sustentabilidad es una prioridad principal para los líderes de la industria. La digitalización y la IA son fundamentales para ayudar a las empresas a avanzar en sus esfuerzos de sustentabilidad. Mire este video y descubra cómo la IA industrial combina machine learning con un conocimiento profundo de la industria para ayudarlo a tomar decisiones más rápidas e inteligentes que reducen las emisiones y los desechos, acercándolo a cero emisiones netas de carbono.

In this short video featuring Antonio Pietri, CEO Aspen Technology, discusses how the self-optimizing plant will be a self-learning, self-adapting, and self-sustaining operation.

In this short video featuring Antonio Pietri, CEO Aspen Technology, explains how the last 40 years have been foundational to the success of industrial AI. In order to accelerate your digital transformation, assets need to run safer, greener, longer and faster.

Our SCM team has curated highlights and insights from OPTIMIZE 2021 available on-demand.

In this episode of the ESG Decoded Podcast, Paige Morse, Industry Marketing Director at AspenTech, chats with Amanda Hsieh on the connective tissue between Artificial Intelligence (AI) and sustainability. AI is a key driver in the achievement of ESG goals as it supports the software capability that can help improve operations and make processes safer for people and the environment. Paige also explains the concept of Industrial AI. ESG Decoded Podcast is powered by Global Affairs Associates.

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Findings from AspenTech® and Longitude’s recent market survey revealed that digital culture and technology adoption provide a competitive edge – but adoption is slow.

In part two, we discuss FMEA as a strategy component for optimizing asset performance and availability.

Prescriptive maintenance technology is transforming how companies increase asset availability. With more advance warning of equipment failures comes more opportunity to mitigate the negative impact of those events.